Literature DB >> 15619002

Is chlamydial heat shock protein 60 a risk factor for oncogenesis?

V Di Felice1, S David, F Cappello, F Farina, G Zummo.   

Abstract

Heat shock protein 60 (HSP60) plays an important role in the protein folding of prokaryotic and eukaryotic cells. Most of the papers published on chlamydial HSP60 concern its role in immune response during infection. In the last decade, exposure to Chlamydia trachomatis has been consistently associated with the development of cervical and ovarian cancer. Moreover, it has been suggested that chlamydial HSP60 may have an anti-apoptotic effect during persistent infection. We hypothesize that the accumulation of exogenous chlamydial HSP60 in the cytoplasm of actively replicating eukaryotic cells may interfere with the regulation of the apoptotic pathway. The concomitant expression of viral oncoproteins and/or the presence of mutations may lead to the ability to survive apoptotic stimuli, loss of replicative senescence, uncontrolled proliferation and, finally neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15619002     DOI: 10.1007/s00018-004-4367-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  11 in total

1.  HSP60 expression during carcinogenesis: a molecular "proteus" of carcinogenesis?

Authors:  Francesco Cappello; Giovanni Zummo
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

2.  Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations.

Authors:  Britton Trabert; Tim Waterboer; Annika Idahl; Nicole Brenner; Louise A Brinton; Julia Butt; Sally B Coburn; Patricia Hartge; Katrin Hufnagel; Federica Inturrisi; Jolanta Lissowska; Alexander Mentzer; Beata Peplonska; Mark E Sherman; Gillian S Wills; Sarah C Woodhall; Michael Pawlita; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

3.  Chlamydia trachomatis infection and human papillomavirus in women with cervical neoplasia in Pernambuco-Brazil.

Authors:  Mayara Costa Mansur Tavares; Jamilly Lopes de Macêdo; Sérgio Ferreira de Lima Júnior; Sandra de Andrade Heráclio; Melânia Maria Ramos Amorim; Maria de Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Mol Biol Rep       Date:  2014-01-07       Impact factor: 2.316

Review 4.  Immunopathogenic consequences of Chlamydia trachomatis 60 kDa heat shock protein expression in the female reproductive tract.

Authors:  Iara Moreno Linhares; Steven S Witkin
Journal:  Cell Stress Chaperones       Date:  2010-02-25       Impact factor: 3.667

5.  Chlamydial Hsp60-2 is iron responsive in Chlamydia trachomatis serovar E-infected human endometrial epithelial cells in vitro.

Authors:  Richard W LaRue; Brian D Dill; David K Giles; Judy D Whittimore; Jane E Raulston
Journal:  Infect Immun       Date:  2007-02-16       Impact factor: 3.441

Review 6.  Role of bacteria in oncogenesis.

Authors:  Alicia H Chang; Julie Parsonnet
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors.

Authors:  Annika Idahl; Eva Lundin; Margaretha Jurstrand; Urban Kumlin; Fredrik Elgh; Nina Ohlson; Ulrika Ottander
Journal:  Infect Dis Obstet Gynecol       Date:  2011-07-28

8.  Microbial infection, inflammation and epithelial ovarian cancer.

Authors:  Xiaohui Xie; Mengyuan Yang; Yiling Ding; Jianlin Chen
Journal:  Oncol Lett       Date:  2017-06-15       Impact factor: 2.967

Review 9.  Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin.

Authors:  Francesco Cappello; Everly Conway de Macario; Valentina Di Felice; Giovanni Zummo; Alberto J L Macario
Journal:  PLoS Pathog       Date:  2009-08-28       Impact factor: 6.823

Review 10.  Heat shock protein 60 and cardiovascular diseases: An intricate love-hate story.

Authors:  Indumathi Krishnan-Sivadoss; Iván A Mijares-Rojas; Ramiro A Villarreal-Leal; Guillermo Torre-Amione; Anne A Knowlton; C Enrique Guerrero-Beltrán
Journal:  Med Res Rev       Date:  2020-08-17       Impact factor: 12.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.